UNIverse - Public Research Portal
MALE avatar

PD Dr. med. Dr. phil Stefan Schandelmaier

Department of Clinical Research
Profiles & Affiliations

Projects & Collaborations

6 found
Show per page
Project cover

STandards for developing REseArch Methods guidance in trials: STREAM

Research Project  | 3 Project Members

Health researchers rely on methods guidance to make decisions about study design, data collection, analysis, reporting, and interpretation. Yet important questions remain about how to develop guidance that reflects methodological evidence and meets researchers’ needs.


STREAM develops practical recommendations for creating trustworthy and useful methods guidance. It addresses how developers can involve relevant people, select and use methodological evidence, formulate recommendations, and present guidance that researchers can understand and apply.


The project combines reviews of existing recommendations and current guidance development practices with interviews with guidance users. An international panel will use these findings to draft STREAM. Guidance developers will then test the recommendations in ongoing projects and provide feedback to refine them.


Stefan Schandelmaier leads STREAM at the University of Basel and University Hospital Basel, working with Malena Chiaborelli, Matthias Briel, and international collaborators.


The Swiss National Science Foundation supports the project through an Ambizione grant.


Project website: stream.methods-research.org

Project cover

Learning from failure - Understanding the mechanisms of trial discontinuation

Research Project  | 6 Project Members

One out of four randomized controlled trials (RCTs) is discontinued; insufficient recruitment of participants is the most frequent reason, in particular in investigator-initiated RCTs. Trials initiated by commercial sponsors are less likely to be discontinued suggesting that professional planning and conduct as well as sufficient funding of RCTs help complete recruitment as planned. Currently, the mechanisms and specific root causes of trial discontinuation remain unclear. Evidence-based guidance for trialists and other stakeholders on how to plan and assess recruitment in RCTs is lacking. In most cases, participants and research ethics committees (RECs) are not informed about discontinuation or publication of trial results. Accounts of the work done so far are not disseminated to the scientific community in up to 60% of discontinued RCTs. This entails ethical problems: The patients' and the public's trust in clinical research is undermined, and finite research resources are wasted. It is unknown to what extent trialists are aware of the ethical implications with trial discontinuation and what their attitudes and views are. We propose three complementary projects that will use both qualitative and quantitative methods to better understand the mechanisms that lead to RCT discontinuation, find ways to meet the associated ethical challenges, and develop guiding principles for involved stakeholders. In Project A we will conduct semi-structured interviews with principal investigators of RCTs discontinued for insufficient recruitment and with key stakeholders of clinical research in Switzerland representing Clinical Trial Units, RECs, the Swiss National Science Foundation (SNSF), the pharmaceutical industry, and Swissmedic. Project B will empirically examine all health-care RCTs funded by the SNSF to explore whether a rigorous selection of trials for funding and monitoring decreases the risk of trial discontinuation including potential effects of full versus partial funding. In Project C we will perform a comprehensive analysis of recruitment patterns from about 500 completed and discontinued RCTs conducted in different countries and settings. It will explore whether insufficient recruitment can reliably be identified at an early stage and determine optimal time points and criteria for the assessment of recruitment progress in RCTs. Using a mixed methods approach, this study will further our understanding of the complex mechanisms leading to failure in trial recruitment and identify potential lever points for targeted interventions. Following on the successfully completed DISCO study it will continue a line of methodological research that is of high relevance to clinical researchers and trial participants in Switzerland and abroad. At a time in which the legal framework of research involving humans is being revised, the study will provide a most needed empirical base for the elaboration of guidance documents to be used by trialists and other stakeholders.
Project cover

A Typology of Methods Reserach (TYPE-ME)

Research Project  | 1 Project Members

Methods research develops, evaluates, and improves the methods we use in health research. Researchers use many different approaches, but inconsistent names and unclear definitions make this work harder to plan, find, and build on.


TYPE-ME provides a shared framework for describing methods research. It distinguishes 15 approaches (how researchers conduct a study) and 14 objectives (what they aim to achieve). For example, researchers might use a simulation study to compare statistical methods, or a consensus study to develop a reporting guideline.


An international team of 11 methodologists, including Stefan Schandelmaier, Malena Chiaborelli, Julian Hirt, and Matthias Briel, developed TYPE-ME through discussion, written feedback, and testing.


Researchers and educators can use TYPE-ME to plan and report studies, review methodological evidence, and teach methods research. The team continues to refine the typology and welcomes feedback from users.


Explore the interactive overview, definitions, examples, and explanations at methods-research.org

Project cover

EU-RESPONSE

Research Networks (Institutional Membership)  | 3 Project Members

EU-RESPONSE is a 5-year project that includes two European Adaptive Platform Trials: DisCoVeRy and EU-SolidAct. The EU-RESPONSE consortium is composed of 22 partners, bringing together multidisciplinary partners from across the continent.


The group at the Division of Clinical Epidemiology is part of the methods and statistical group and co-leads specific meta-research projects such as several individual participant data meta-analyses (IPDMAs).


So war, we have conducted two large-scale IPDMAs to summarise all available randomised evidence on a) remdesivir and b) JAK inhibitors among hospitalised COVID-19 patients. Both IPDMAs contained more than >10'000 randomized patient data from more than 10 trial teams. The remdesivir IPDMA was published in The Lancet Respiratory Medicine, directly influenced the NICE guidelines in the UK, received high media attention, was cited in two editorials, and presented at the prestigious CROI conference 2023. The JAK inhibitor IPDMA (https://www.jakinhibitoripdma.org/) is currently under review at The Lancet Resp Med and in discussion at the WHO COVID-19 guidelines team for the upcoming update of their treatment guidelines.

Project cover

Instrument to assess the Credibility of effect Modification ANalyses (ICEMAN)

Research Project  | 1 Project Members

Subgroup analyses can reveal differences in treatment effects between patient groups, but chance and analytical choices frequently produce misleading findings. ICEMAN helps researchers judge how credible these findings are.


The instrument has separate versions for randomized controlled trials and meta-analyses of randomized trials. It guides users through questions about prior hypotheses, earlier evidence, statistical support, and analytical choices. Users weigh these considerations to rate overall credibility from very low to high.


Stefan Schandelmaier led the development of ICEMAN with an international team. The team published the instrument in 2020. ICEMAN work toegtehr with Cochrane reviews and the GRADE approach.


Access the assessment forms, online tool, user manual, and reporting templates at iceman.help

Project cover

Library of Guidance for Health Scientist (LIGHTS)

Research Project  | 4 Project Members

Finding useful methods guidance can be difficult. Relevant articles appear across many journals, use inconsistent terminology, and often lack adequate indexing in general research databases.


LIGHTS brings this literature together in a freely accessible, searchable database. It covers guidance for planning, conducting, analysing, reporting, and appraising health research, including tutorials, methodological recommendations, reporting guidelines, and quality assessment tools.


Users can narrow their searches by study type, methodological topic, research context, and type of guidance. The search also matches alternative terms for methodological concepts, helping users find relevant articles even when authors use different terminology.


Stefan Schandelmaier founded LIGHTS. An international team of health researchers, methodologists, and information specialists develops and maintains the collection. LIGHTS helps researchers make methodological choices, educators find teaching resources, and guidance developers build on existing work. We also use it to research methods guidance as a study type.


Search the library at lights.science